Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)

NCT04575428 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04575428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04575428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2020
Completion date
June 16, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure